Biotechnology
TLX
7.63
price up icon1.73%   0.13
after-market Dopo l'orario di chiusura: 7.63

Telix Pharmaceuticals Ltd Adr (TLX)
full-star
loading
Panoramica Notizia Cronologia dei prezzi Forum Previsione
Precedente Chiudi:
$7.50
Aprire:
$7.58
Volume 24 ore:
80,704
Relative Volume:
0.62
Capitalizzazione di mercato:
$2.55B
Reddito:
$417.75M
Utile/perdita netta:
$32.27M
Rapporto P/E:
78.26
EPS:
0.0975
Flusso di cassa netto:
-
1 W Prestazione:
+1.87%
1M Prestazione:
-21.10%
6M Prestazione:
-51.37%
1 anno Prestazione:
-50.29%
Intervallo 1D:
Value
$7.58
$7.68
Intervallo di 1 settimana:
Value
$7.38
$7.68
Portata 52W:
Value
$7.38
$30.36

Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile

Name
Nome
Telix Pharmaceuticals Ltd Adr
Name
Settore
Healthcare (1113)
Name
Industria
Biotechnology (621)
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
554
Name
Cinguettio
Name
Prossima data di guadagno
2025-10-14
Name
Ultimi documenti SEC
Name
TLX's Discussions on Twitter

Confronta TLX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TLX
Telix Pharmaceuticals Ltd Adr
 7.63 2.51B 417.75M 32.27M 0 0.0975
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 469.68 122.84B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 801.01 85.37B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 399.40 55.82B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 795.57 50.67B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 170.27 37.54B 447.02M -1.18B -906.14M -6.1812

Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-18 Iniziato Citigroup Buy
2025-08-28 Downgrade JP Morgan Overweight → Neutral
2025-07-03 Iniziato H.C. Wainwright Buy
2025-06-05 Iniziato Wedbush Outperform
2024-11-15 Iniziato UBS Buy

Telix Pharmaceuticals Ltd Adr Borsa (TLX) Ultime notizie

pulisher
Jan 08, 2026

Telix Pharmaceuticals Ltd. Sued for Securities Law ViolationsContact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz

Jan 08, 2026
pulisher
Jan 08, 2026

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 08, 2026
pulisher
Jan 02, 2026

FCX IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important January 12 Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Jan 02, 2026
pulisher
Jan 02, 2026

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. LawsuitTLX - Sahm

Jan 02, 2026
pulisher
Dec 30, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Dec 30, 2025
pulisher
Dec 30, 2025

Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX)January 9, 2026 Deadline to JoinContact Levi & Korsinsky - Sahm

Dec 30, 2025
pulisher
Dec 23, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Stockholders to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Dec 23, 2025
pulisher
Dec 17, 2025

[6-K] Telix Pharmaceuticals Ltd Current Report (Foreign Issuer) | TLX SEC FilingForm 6-K - Stock Titan

Dec 17, 2025
pulisher
Dec 16, 2025

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately - Finviz

Dec 16, 2025
pulisher
Dec 16, 2025

Telix Pharma (TLX) Makes Progress With New Study - Finviz

Dec 16, 2025
pulisher
Dec 08, 2025

Telix Pharmaceuticals (TLX) files Form 6-K on first ProstACT Global patient - Stock Titan

Dec 08, 2025
pulisher
Dec 02, 2025

ATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action Lawsuit - Stock Titan

Dec 02, 2025
pulisher
Nov 28, 2025

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 28, 2025
pulisher
Nov 26, 2025

Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 26, 2025
pulisher
Nov 25, 2025

Investors in Telix Pharmaceuticals Ltd. Should Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz

Nov 25, 2025
pulisher
Nov 25, 2025

Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors After Class Action Filing - Stock Titan

Nov 25, 2025
pulisher
Nov 24, 2025

TLXTelix Pharmaceuticals Ltd ADR Latest Stock News & Market Updates - Stock Titan

Nov 24, 2025
pulisher
Nov 19, 2025

Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing - Stock Titan

Nov 19, 2025
pulisher
Nov 18, 2025

Telix Pharmaceuticals Limited Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsTLX - Stock Titan

Nov 18, 2025

Telix Pharmaceuticals Ltd Adr Azioni (TLX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Simile a TLX

biotechnology GMAB
$33.63
price down icon 0.80%
biotechnology RVMD
$107.39
price up icon 4.56%
biotechnology INCY
$105.92
price down icon 4.21%
biotechnology BNTX
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
biotechnology INSM
$170.27
price down icon 3.26%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):